Cancer BiologybioRxivPreprint
A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia
Luke Jones, Oleksii S. Rukhlenko, Tânia Dias…·Jonathan Bond
This paper uses a structure-based model to identify synergistic RAF inhibitor combinations effective against RAS-mutant AML in vitro and in vivo.
1 citation